Advanced Inhalation Therapies, Ltd. IPO Research Information

Advanced Inhalation Therapies, Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Advanced Inhalation Therapies, Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Advanced Inhalation Therapies, Ltd.	AITPU - NASDAQ	$15.00-$15.00	$0.00	$0.00	333,333
Underwriter(s): Joseph Gunnar & Co.
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2015-08-25 Updated Prospectus 2016-01-21 Updated Prospectus 2016-02-17

About Advanced Inhalation Therapies, Ltd. (adapted from Advanced Inhalation Therapies, Ltd. prospectus):
They are an emerging biopharmaceutical company that is developing a single proprietary 160 parts per million (ppm) nitric oxide (NO) formulation and delivery system to treat various respiratory infections for which current treatments have limited effectiveness.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "AITPU" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.